raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:102

Multiple system atrophy

Synonyms: MSA · Multisystem atrophy

Type
Disease
Group
Disorder
Inheritance
Multigenic/multifactorial, Not applicable
Age of onset
Adult
Status
active

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure (cardiovascular and/or urinary), parkinsonism, cerebellar impairment and corticospinal signs with a median survival of 6-9 years.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMultiple system atrophyMSA · Multisystem atrophy
frAtrophie multisystématiséeAMS · Atrophie multisystémique · MSA
deMultiple SystematrophieMSA · Multisystematrophie
esAtrofia multisistémicaAMS
itAtrofia sistemica multiplaAtrofia multisistemica · MSA
nlMultipele systeematrofieMSA · Multisysteematrofie
ptAtrofia sistémica múltipla
plZanik wieloukładowyMSA
csMnohočetná systémová atrofieMSA · Multisystémová atrofie
ukМножинна системна атрофіяMSA · Мультисистемна атрофія
zh多系统萎缩多系统萎缩
trÇoklu sistem atrofisiMSA · Multisistem atrofisi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM146500Evalidated
ICD-10G23.2BTNTattributedvalidated
ICD-10G23.3BTNTattributedvalidated
ICD-118D87.0Especificvalidated
MONDO0007803Evalidated
MeSHD019578Evalidated
UMLSC0393571Evalidated
GARD7079Evalidated
MedDRA10064060Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

Children (2):

Codes that Orphanet moved or referred to this one:

4

Genes

0 direct · 2 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
COQ2ORPHA:98933Multiple system atrophy, parkinsonian typeMajor susceptibility factor inAssessedHGNC:25223ENSG000001730856098254q21.23coenzyme Q2, polyprenyltransferase23758206[PMID]
COQ2ORPHA:227510Multiple system atrophy, cerebellar typeMajor susceptibility factor inAssessedHGNC:25223ENSG000001730856098254q21.23coenzyme Q2, polyprenyltransferase23758206[PMID]
5

Prevalence and incidence

13 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0003.7 / 100 000EuropeValue and classNot yet validatedORPHANET
Point prevalence1-9 / 100 0003.5 / 100 000WorldwideValue and classValidated[EXPERT]
Annual incidence1-9 / 100 0001.8 / 100 000WorldwideValue and classValidated[EXPERT]
Annual incidence1-9 / 1 000 0000.7 / 100 000IcelandValue and classValidated23192520[PMID]
Point prevalence1-9 / 100 0003.4 / 100 000IcelandValue and classValidated23192520[PMID]
Annual incidence1-9 / 100 0002.1 / 100 000SwedenValue and classValidated20108376[PMID]
Point prevalence1-9 / 100 0004.4 / 100 000United KingdomValue and classValidated10577638[PMID]
Annual incidence1-9 / 1 000 0000.6 / 100 000United StatesValue and classValidated9371909[PMID]
Point prevalence1-9 / 100 0001.9 / 100 000FranceValue and classValidated10841152[PMID]_15272223[PMID]
Annual incidence1-9 / 1 000 0000.11 / 100 000Russian FederationValue and classValidated20108378[PMID]
Point prevalence1-9 / 100 0004.9 / 100 000ItalyValue and classValidated9613728[PMID]
Point prevalence1-5 / 10 00010.3 / 100 000JapanValue and classValidated20880268[PMID]_19169038[PMID]
Point prevalence1-9 / 100 0002.3 / 100 000Faroe IslandsValue and classValidated9270572[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

27 annotations · validated 2018-03-07
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012332Abnormal autonomic nervous system physiologyDiagnostic criterion
HP:0012658Abnormal brain FDG positron emission tomography
HP:0007256Abnormal pyramidal signDiagnostic criterion
HP:0002494Abnormal rapid eye movement sleep
HP:0005341Autonomic bladder dysfunctionDiagnostic criterion
HP:0008652Autonomic erectile dysfunction
HP:0002530Axial dystonia
HP:0002067Bradykinesia
HP:0100595Camptocormia
HP:0010536Central sleep apnea
HP:0002019Constipation
HP:0001260Dysarthria
HP:0030015Female anorgasmia
HP:0002359Frequent falls
HP:0002066Gait ataxia
HP:0000640Gaze-evoked nystagmus
HP:0002310Orofacial dyskinesia
HP:0004926Orthostatic hypotension due to autonomic dysfunctionDiagnostic criterion
HP:0012670Orthostatic syncope
HP:0001300ParkinsonismDiagnostic criterion
HP:0002172Postural instability
HP:0002174Postural tremor
HP:0002073Progressive cerebellar ataxiaDiagnostic criterion
HP:0030880Raynaud phenomenon
HP:0002322Resting tremor
HP:0002063Rigidity
HP:0010307StridorDiagnostic criterion

Annotation source: 18725592[PMID]_14747001[PMID]_23758206[PMID]_14219099[PMID]_14446364[PMID]

7

Sources for this card